Biotech Breakthrough “Like Science Fiction,=?UTF-8?B?4oCd?= Remarks Doctor

Dear Reader, Its codename is “CTX.” And a Nobel Prize winner has gone on record stating this tech could soon mean the end of human disease as we know it. Its recent shocking trial results have been hailed as a “Landmark.” As one researcher and surgeon puts it, this tech feels “like science fiction.” It's set to generate trillions of dollars in the months and years ahead. It's backed by a laundry list of billionaires including Elon Musk, Jeff Bezos, Bill Gates, and Sean Parker. Google, Stanford, and the FDA have all lined up behind it too. Yet somehow, this tech doesn't belong to Big Pharma or Big Tech… It belongs to a small group of biotech firms you've probably never heard of. No matter what's happening in the world around us these days… If you can invest in this tech now, before it breaks out into the public eye, it could very well be the financial move of a lifetime. I go over all the details in my recent interview with national television host Chris Hurt. Click here to watch or read for yourself. I'll see you there. Regards, Jeff Brown Founder, Brownstone Research

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.